MA
BLFS icon

MCF Advisors’s BioLife Solutions BLFS Stock Holding History

MCF Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5K Buy
763
+292
+62% +$6.83K ﹤0.01% 886
2026
Q1 		$8.99K Buy
471
+134
+40% +$2.96K ﹤0.01% 988
2025
Q4 		$8.15K Hold
337
– – ﹤0.01% 868
2025
Q3 		$8.6K Buy
337
+47
+16% +$1.11K ﹤0.01% 716
2025
Q2 		$6.25K Sell
290
-94
-24% -$2.12K ﹤0.01% 727
2025
Q1 		$8.77K Hold
384
– – ﹤0.01% 672
2024
Q4 		$9.97K Buy
384
+154
+67% +$3.83K ﹤0.01% 660
2024
Q3 		$5.76K Buy
+230
New +$5.43K ﹤0.01% 730

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MCF Advisors's BLFS Position: Q2 2026 in Review

MCF Advisors increased its BioLife Solutions (BLFS) stake by 62% in Q2 2026, buying an estimated $6.83K and bringing the position to 763 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

MCF Advisors first reported a position in BLFS in Q3 2024 and has held it in 8 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • MCF Advisors held 763 shares of BioLife Solutions worth $21.5K as of Q2 2026.
  • MCF Advisors bought 292 BioLife Solutions shares in Q2 2026, an estimated $6.83K.
  • BioLife Solutions made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #886 holding.
  • MCF Advisors first reported a position in BioLife Solutions in Q3 2024 and has held it in 8 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.